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Abstract
α-Bisabolol (BSB) is a plant-derived sesquiterpene alcohol able to trigger regulated cell death in transformed cells,
while deprived of the general toxicity in several mouse models. Here, we investigated the involvement of lysosomal
and mitochondrial compartments in the cytotoxic effects of BSB, with a specific focus on the BH3-only activator
protein BID. We found that BSB particularly accumulated in cancer cell lines, displaying a higher amount of lipid rafts as
compared to normal blood cells. By means of western blotting and microscopy techniques, we documented rapid
BSB-induced BID translocation to lysosomes and mitochondria, both of them becoming dysfunctional. Lysosomal
membranes were permeabilized, thus blocking the cytoprotective autophagic flux and provoking cathepsin B leakage
into the cytosol. Multiple flow cytometry-based experiments demonstrated the loss of mitochondrial membrane
potential due to pore formation across the lipid bilayer. These parallel events converged on neoplastic cell death, an
outcome significantly prevented by BID knockdown. Therefore, BSB promoted BID redistribution to the cell death
executioner organelles, which in turn activated anti-autophagic and proapoptotic mechanisms. This is an example of
how xenohormesis can be exploited to modulate basic cellular programs in cancer.
Introduction
α-Bisabolol (BSB) is a vegetal highly lipophilic sesqui-
terpene taking part in plant immune defense against
microbial insults1. Similarly to other plant metabolites, it
also succeeds in interacting with diverse intracellular
pathways of normal mammalian cells2, which usually
mount anti-inflammatory and proresolving responses
under BSB3,4.
In addition, several preclinical studies from our group and
others revealed that BSB exerts pleiotropic effects against a
wide range of transformed cells, eventually leading to
bioenergy dissipation, membrane permeabilization, and
regulated cell death (RCD)5–11. Because of its low toxicity at
the therapeutic dosages, easy administration route and
opportunity for synergism5,11, BSB has already been tested
in animal models11 and proposed as a novel antineoplastic
agent for treating acute lymphoblastic leukemia5,8, chronic
myeloid and lymphocytic leukemias5,7, malignant gliomas9,
and pancreatic carcinomas11.
However, the sequence of intracellular events triggered
by BSB and leading to apoptotic cell death is still lacking
clear distinction of elements. Lipid rafts, specialized
membrane domains that compartmentalize either pro-
survival or proapoptotic signaling molecules12, have been
reported to directly interact with BSB, allowing it to be
absorbed into the plasma membrane10. Once entered the
cell, a series of injuries involving mitochondria and lyso-
somes seems to drive the cytolytic program activated by
BSB6. In chronic lymphocytic leukemia cells, for example,
it promoted the opening of mitochondrial membrane
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pores and destabilized the lysosomal compartment,
eventually favoring the collapse of the cell-rescuing
autophagic apparatus7.
Molecular interactions priming the death cascade are
even less clear. The proapoptotic, BH3-only protein BID
has been hypothesized to orchestrate the proximal
response to BSB, based on some basic observations: it can
be recruited into lipid rafts by some apoptosis-inducing
agents13; it functionally links extrinsic and intrinsic
apoptotic pathways, both ending with mitochondrial
membrane depolarization and caspase activation14; and it
is involved in the lipid exchange and trafficking from
plasma membranes to intracellular ones15. Proceeding on
this track, we previously demonstrated that BID moved
into flotillin-rich membrane regions upon BSB treatment
and, at least in cell-free conditions, it interacts with BSB
through its methionine 194, which is part of the hydro-
phobic groove present on its surface10. Therefore, the core
proapoptotic protein BID might be considered as a can-
didate cytoplasmic receptor for BSB, both of them
appearing colocalized in lipid rafts.
By using HeLa and Jurkat cells as in vitro cancer
models, here we demonstrate that BID is rapidly mobi-
lized upon BSB treatment and its presence is required for
full cytotoxicity to occur. Therefore, we present the main
cellular events triggered by BSB, involving lysosomal and
mitochondrial disruption and ending with neoplastic
cell death.
Results
Lipid raft components and BSB uptake
It was previously suggested that BSB enter cells through
lipid rafts, highly dynamic sterol- and sphingolipid-enriched
membrane domains that function as platforms to con-
centrate signal transduction machineries. Ganglioside M1
(GM1), flotillin-1, and cholesterol are three of the main raft
components and are widely used as markers for lipid raft
cellular amount10,12. To test the possibility that BSB speci-
ficity for transformed cells may reside in different lipid raft
contents as compared to the normal counterparts, we first
quantified by flow cytometry GM1 and flotillin-1 in either
peripheral blood mononuclear cells (PBMC) or a panel of
cancer cell lines (Fig. 1a), some of them being also visualized
by confocal microscopy (Fig. 1b). With respect to PBMC,
most tumor cells had superior amounts of GM1 and flo-
tillin-1, detected by means of the affinity to cholera toxin B
and a specific monoclonal antibody, respectively. Cellular
cholesterol content, determined by high-performance liquid
Fig. 1 Lipid rafts and BSB uptake. a Expression of GM1 and flotillin-1 as assessed by flow cytometry in different cell types. Data were expressed as
arbitrary units dividing the MFI by the median forward scatter (size) in each sample. *p < 0.05, as compared to PBMC. b Immunofluorescence
detection of GM1 (Alexa Fluor 488) and Flotillin-1 (Cy-3) on different cell types. Samples were counterstained with DAPI and visualized by confocal
microscopy. Magnification 63×. Scale bar: 17 μm. c Plasma membrane content of cholesterol. *p < 0.05 as compared to PBMC. d BSB concentrations
in cellular compartments of different cells treated with 40 µM BSB for 24 h. *p < 0.05, as compared to PBMC. Mean values and s.d. of five independent
determinations for each cell type were plotted.
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chromatography (HPLC), also resulted on average sig-
nificantly more abundant in neoplastic cells than PBMC
(Fig. 1c). In parallel, we measured BSB content in subcellular
fractions. As compared to PBMC, HeLa, Jurkat, CML-T1,
K562, and LAMA-84 cancer cells internalized higher
amounts of BSB, which accumulated in the cytosolic/mito-
chondrial fraction and, to a lesser extent, in cell membranes
and nuclei (Fig. 1d). Therefore, lipid raft amount correlated
with BSB intracellular content. In addition, it correlated with
cell sensitivity to BSB, as evaluated by 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and
expressed as μM IC50 (half-maximal inhibitory concentra-
tion; Table 1). Our previous observation that filipin III, a
polyene antibiotic disrupting cholesterol-rich raft fractions,
rescued cells from BSB-induced cytotoxicity further
strengthens the importance of membrane rafts in the BSB
mechanism of action6.
Cytostatic and cytotoxic effects of BSB
We previously reported that BSB decreased viability of
several neoplastic cell types5,7,8,10. Here we analyzed in
more detail the cytostatic and cytotoxic effects of BSB in
HeLa and Jurkat cells. Flow cytometric analysis of DNA
content revealed that 24-h treatment with BSB arrested
cells in G0/G1 phase in a concentration-dependent man-
ner. At the same time, the number of S phase cells
decreased (Fig. 2a). Annexin-V/TO-PRO-3 staining per-
formed after 5-h BSB treatment showed an increase of
both early apoptotic (Annexin-V+/TO-PRO-3−) and late
apoptotic/necrotic cells (Annexin-V+/−/TO-PRO-3+; Fig. 2b).
Exposure to 80 μM BSB also increased the level of the
apoptotic marker cleaved poly(ADP-ribose) polymerase
(PARP) in Jurkat cells (Fig. 2c; p < 0.05). These results
indicated that BSB exerted a direct growth inhibitory
effect on transformed cells that was mediated through cell
cycle arrest in G0/G1 phase and induction of RCD.
BSB-induced BID translocation to mitochondria and
lysosomes
Upon BSB entry, a number of intracellular pathways
involving apoptotic and autophagic mechanisms must be
triggered out to provoke the cell death we observed. Based
on our previous biochemical studies, demonstrating that
BSB can recruit and directly interact with BID within lipid
rafts10, we focused on this BH3-only protein and analyzed
its subcellular fate upon BSB stimulation. HeLa cells were
transfected with pDsRed2-BID expression vector, whose
product was monitored by confocal microscopy to assess
its redistribution through the intracellular compartments.
As soon as 1 h after BSB stimulation, BID translocated to
mitochondria and lysosomes, as evidenced by its tight
colocalization with MitoTracker and LysoTracker fluor-
escent dyes, respectively (Fig. 3a, b and Supplementary
Movie 1). This was followed by organelle damage, as
indicated by the loss of fluorescence intensity of mito-
chondria and lysosomes, which started as soon as 3 h after
BSB stimulation (Fig. 3a). Kinetic immunoblot analysis
demonstrated that both full-length and truncated BID
(tBID) were present in mitochondrial extracts of BSB-
treated cells (Fig. 3c; p < 0.05), further supporting its
subcellular relocation upon BSB exposure. Thus, the cell
death executioner organelles, mitochondria and lyso-
somes, are targets of BID being mobilized by BSB.
Autophagic flux impairment and lysosome destabilization
The lysosomal compartment, one of the main targets of
BSB, is critically involved in the autophagic pathway, a
regulated self-digestion process triggered by unfavorable
conditions, in which selected cytoplasmic material is
sequestered into double-membrane vesicles (autophago-
somes) and delivered for lysosomal degradation. Two
fundamental components contribute to the autophagic
flux: (a) autophagosome nucleation and maturation, a
Table 1 Relationship between lipid raft components (GM1, flotillin-1, and cholesterol) and sensitivity to BSB, as
expressed by IC50 (μM) in PBMC and human cancer cell lines.
Cell line GM1 (a) Flotillin-1 (b) Cholesterol (c) a+ b+ c IC50 [Cellular BSB]
PBMC + + + +++ 181 70 ± 9
HeLa ++ + ++ +++++ 70 250 ± 20
JURKAT +++ + + +++++ 80 541 ± 27
CML-T1 +++ + + +++++ 53 669 ± 47
K562 ++ ++ ++ ++++++ 73 407 ± 17
MEG-01 + ++ + ++++ 63 nd
LAMA-84 ++ ++ + +++++ 68 765 ± 109
nd not done
GM1 and flotillin-1 were expressed as arbitrary units of fluorescence based on the results of fluorescence-activated cell sorting analysis. The ratio between mean
fluorescence intensity (MFI) and mean forward scatter of the cells was determined (≤15=+; 15–100=++; >100=+++), to correct for difference in cell sizes.
Cholesterol was expressed as pg/cell (≤3=+; >3=++). [BSB] was expressed as pmol/106 cells
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microtubule-associated protein 1 light chain 3 (LC3) and
Beclin 1-dependent process; (b) functional lysosomes,
eventually fusing with autophagosomes to efficiently
degrade the autophagic cargo16.
(a) By means of Cyto-ID-Green staining, we have pre-
viously shown that BSB increased autophagosome for-
mation in a dose-dependent manner. This may indicate
either induction of autophagic flux or accumulation of
autophagosomes due to a downstream blockage6. To
clarify this aspect, we assessed the turnover of LC3-II, a
widely used marker for autophagosome formation
resulting from the lipidation of LC3-I, in the presence or
absence of two lysosomal degradation inhibitors, E-64D
and pepstatin A. In E-64D and pepstatin A-treated cells,
an autophagy promoter will increase LC3-II levels,
whereas an autophagy inhibitor will not change them17.
Stimulation with BSB increased LC3-II amount as com-
pared to control cells (p < 0.05). However, pretreatment
with E-64D and pepstatin A did not further augment LC3-
II levels (Fig. 4a; p= ns (not significant) between BSB and
BSB plus autophagy inhibitors), demonstrating BSB-
dependent impairment of autophagic flux. Of note,
expression of Beclin 1 protein, which is dispensable for
LC3-II lipidation but required for the subsequent autop-
hagosome maturation18, was clearly reduced after 16-h
treatment with BSB (Fig. 4b; p < 0.05). Conversely, Beclin 1
messenger RNA, evaluated by quantitative real‐time poly-
merase chain reaction (RT-qPCR), significantly increased
upon BSB exposure both in HeLa and Jurkat cells (fold
change of 4.3 ± 0.9 and 3 ± 0.2 at 16 h, respectively, p <
0.05, not shown), suggesting enhanced Beclin 1 protein
degradation rather than transcriptional suppression.
Therefore, BSB led to the accumulation of Beclin 1-
deficient, poorly progressing autophagosomes.
(b) By staining cells with LysoTracker green (LTG), we
noticed lysosome accumulation as soon as 1 h after BSB
administration (Fig. 3a), further indicating an altered
autophagic process. Afterward, LTG uptake progressively
decreased (Figs. 3a and 4c). This was compatible with an
enlargement/accumulation and subsequent collapse of
lysosomal compartment. To evaluate the effects of BSB on
lysosomal membrane stability, we used the fluorescent
lysosomotropic dye acridine orange (AO). The AO-
relocation assay, aimed at the assessment of AO leakage
outside the lysosome19, showed an increase in cytosolic
green fluorescence after treatment with BSB (Fig. 4d; left).
Accordingly, the AO-uptake assay, directly measuring the
AO accumulation inside the lysosome, demonstrated a
decrease in lysosomal red fluorescence (Fig. 4d; right). To
further confirm the BSB-triggered loss of lysosomal
membrane integrity, we stained cells with a fluorophore-
labeled antibody detecting cathepsin B, a cysteine protease
involved in enzymatic digestion of lysosomal content. A
5-h exposure to BSB determined lysosome-to-cytosol
Fig. 2 Cell cycle blockage and proapoptotic activity of BSB. a Top:
a representative flow cytometric experiment demonstrating cell cycle
arrest by BSB. Jurkat cells treated with 20, 40, and 80 µM BSB for 24 h
were incubated with 10 µM Vybrant DyeCycle orange stain for 15 min.
Bottom: statistical analysis (mean and s.d.) of the cell cycle phases. b
Cytometric PolyChromatic plot analysis of apoptosis after 5-h
treatment with 80 µM BSB. Jurkat cells were stained with Annexin-V
and TO-PRO-3 to distinguish between alive (Annexin-V−/TO-PRO-3−),
early apoptotic (Annexin-V+/TO-PRO-3−), and late apoptotic/necrotic
cells (Annexin-V+/−/TO-PRO-3+). c Western blot showing the
appearance of the cleaved form of PARP (cPARP) following 1, 3 and
5 h treatment with 80 μM BSB in Jurkat cells. Each experiment is
representative of five.
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redistribution of cathepsin B, as evidenced by the diffuse
fluorescence pattern together with the presence of large
cytoplasmic cathepsin B aggregates (Fig. 4e).
Overall, BSB-induced Beclin 1 decrease and lysosomal
disruption hindered the autophagic flux, which was
likely impeded at the stage of autophagosome. The
collapse of autophagic machinery eventually favored the
leakage of lysosomal proapoptotic cathepsins through-
out the cytosol.
Trigger for mitochondrial damage
BID translocation to mitochondria (Fig. 3a–c) was
expected to initiate the intrinsic apoptotic pathway
through mitochondrial membrane permeabilization
(MMP), considered as the point of no return toward cell
death20. We measured MMP by means of JC-1, a mito-
chondrial transmembrane potential (ΔΨm)-sensitive dye,
which accumulates in well-polarized mitochondria in
form of red fluorescent aggregates8. Figure 5a shows that
Fig. 3 Fate of BID following BSB stimulation. a Colocalization of pDsRed2-BID with the specific mitochondrial (MitoTracker Deep Red FM) and
lysosomal (LysoTracker green DND-26) dyes was analyzed by time-lapse imaging confocal microscopy. pDsRed2-BID-transfected HeLa cells were
stained with the probes, stimulated with 80 μM BSB and monitored for 3 h. One hour after addition of BSB, the uniformly distributed red fluorescence
in the cytosol, spatially distinct from the blue granular mitochondrial and the green granular lysosomal ones, appeared translocated and colocalized
with mitochondria (purple) and lysosomes (yellow), as clearly appreciable at the level of the single optical slices. Three hours after addition of BSB, the
apoptotic features were clear: the uniform red pattern was completely replaced by red clusters; blue and green fluorescences (and respective
colocalizations) decreased as a consequence of dye leakage. Scale bar: 17 μm. b Key frames selected from Supplementary Movie 1. 80’ stimulation
with BSB led to the overlap between green-stained mitochondria and red fluorescent BID, generating yellow signals (white arrows). Scale bar: 17 μm.
c Kinetic western blot demonstrating the appearance of tBID and, to a lesser extent, full-length BID in the mitochondrial fraction. The positive control
(C+) of BID cleavage is etoposide. The shown experiment is representative of three.
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treatment with 40 μM BSB resulted in a time-dependent
decrease of JC-1 red fluorescence, shifting downward due
to ΔΨm dissipation. This was further confirmed by using
tetramethylrhodamine methyl ester (TMRM), a poten-
tiometric fluorescent probe accumulated by mitochondria
in a log scale as ΔΨm increases, according to Nernst
equation in a voltage-dependent manner21. Considering
180mV as control cell ΔΨm value21, we calculated a
significant fall to 172 ± 1.5, 162 ± 4, and 81 ± 20 mV in
cells treated with 20, 40, and 80 µM BSB, respectively. As
such, there was a dose-dependent increase of ΔΔΨm (Fig.
5b), defined as the difference between control cell- and
treated cell-ΔΨm.
BSB-induced MMP may also result from the opening of
mitochondrial permeability transition pore (mPTP). To
explore this possibility, the calcein acetoxymethyl ester
(calcein AM) assay was performed. Calcein AM becomes
fluorescent in cells after cleavage of AM groups through
cytosolic and mitochondrial esterases. CoCl2 cannot enter
mitochondria when mPTP is closed, so that it quenches
cytosolic fluorescence leaving unmodified the mitochon-
drial one7. Control and BSB-treated cells showed similar
MFI when loaded with only calcein AM. However, CoCl2
addition led to a far more MFI decrease in treated cells as
compared to control due to the quenching of both cyto-
solic and mitochondrial fluorescence (Fig. 5c), reflecting
the irreversible mPTP opening.
Mitochondrial membrane depolarization induced by
BSB could associate with altered mitochondrial mor-
phology22. To investigate this point, HeLa cells were
transfected with mitochondrial-targeted green fluorescent
protein (GFP) and mitochondrial morphology was
Fig. 4 Autophagy impairment and lysosomal collapse induced by BSB. a Expression of LC3-I and LC3-II in Jurkat cells left untreated (control) or
treated for 16 h with BSB, BSB plus pepstatin A and E-64D (BSB+), or pepstatin A and E64D without BSB (+). b Expression of Beclin 1 in Jurkat cells
treated or not with BSB for 6 and 16 h. c Fluorescence microscopy of lysosomal destabilization evaluated by LTG-uptake assay in Jurkat cells. Shown is
the shift from a punctate staining (intact lysosomes from untreated cells) to a diffuse cytoplasmic signal (disrupted lysosomes from treated cells).
Scale bar: 12 μm. d Flow cytometry and fluorescence microscopy assessment of lysosomal membrane permeabilization. AO-relocation assay (left):
Jurkat cells stained with the metachromatic fluorophore AO were exposed to 80 µM BSB for 5 h. Leakage of lysosomal content into the cytoplasm
was measured as an increase in green fluorescence (control 11,590 ± 1243 vs treated 17,185 ± 2532, p < 0.05). AO-uptake assay (right): Cells treated
with 80 μM BSB for 5 h were stained with AO. Reduced lysosomal AO accumulation was measured as a reduction in red fluorescence (control
15,290 ± 2379 vs treated 1600 ± 200, p < 0.001). Scale bar: 12 μm. e Fluorescence microscopy evaluation of the lysosomal protease cathepsin B after 5-
h treatment of Jurkat cells with 80 µM BSB. Cathepsin B was released into the cytosol upon BSB stimulation, as evidenced by the diffuse fluorescence
pattern. A large cytoplasmic cathepsin B aggregate was also evident. Samples were counterstained with DAPI. Scale bar: 12 μm.
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Fig. 5 Mitochondrial damage triggered by BSB. a JC-1 technique demonstrating ΔΨm dissipation caused by BSB in Jurkat cells. Flow cytometry (left,
polychromatic plot analysis): The normal (high) ΔΨm of untreated cells moved downward (intermediate and low ΔΨm) after treatment with 40 μM BSB,
at the indicated time points. This was due to the progressive JC-1 dislocation from mitochondria to the cytosol. Fluorescence microscopy (right): In
untreated cells, well-polarized mitochondria appeared as a red punctate fluorescence; after treatment with 40 μM BSB red fluorescence was lowered
and the green one was increased, indicating loss of ΔΨm. Scale bar: 12 μm. b ΔΔΨm values, as evaluated by TMRM staining, of Jurkat cells exposed to
20, 40, and 80 µM BSB for 5 h were 7.6 ± 1.5, 18 ± 4, and 98.3 ± 20.6, respectively, as compared to untreated ones, p < 0.05. c Impairment of mPTP
function after 5-h treatment with 40 μM BSB, as assessed by calcein AM assay in Jurkat cells. The fluorescence intensity of calcein AM-loaded cells was
similar between resting and treated ones (1554 ± 120 vs 1568 ± 115). Quencing of calcein AM fluorescence by CoCl2 (Co) was significantly reduced in
treated cells as compared to control (18 ± 4 vs 34 ± 3, p < 0.05), indicating mPTP opening. Scale bar: 12 μm. d HeLa cells transfected with mito-GFP
were treated with 80 µM BSB or vehicle for 24 h and mitochondrial morphology was monitored. Upper panel: representative images of mitochondrial
network by live cell imaging. Scale bar: 10 µm. Lower panel: aspect ratio analysis represented as histogram with s.e.m. Data indicate significant
fragmentation of mitochondrial network upon BSB exposure. A total of 500 measurements for each condition have been made. *p < 0.001. For panels
a, c, and d, shown experiment is representative of at least five.
Rigo et al. Cell Death and Disease          (2019) 10:889 Page 7 of 13
Official journal of the Cell Death Differentiation Association
assessed in live cells by confocal microscopy. BSB-treated
cells displayed more discrete, less interconnected, mito-
chondria as compared to control. In particular, aspect ratio
(defined as the ratio between the major axis and minor
axis of each particle) decreased after BSB exposure, clearly
indicating mitochondrial network fragmentation (Fig. 5d).
These findings suggested that BSB perturbed mito-
chondrial membranes and dissipated ΔΨm, two well-
recognized events precipitating, or at least amplifying,
RCD pathways14.
BID knockdown protects cancer cells from BSB-induced
cytotoxicity
To verify the actual contribution of BID in the cytotoxic
program of BSB, we generated BID-knockdown HeLa
cells and analyzed organelle damage after BSB exposure.
BID silencing partially protected cancer cells from BSB-
induced mitochondrial depolarization, as evidenced by
the decreased percentage of green-emitting JC-1 mono-
mers compared to control (Fig. 6a). In addition, BSB-
triggered lysosomal membrane permeabilization was
attenuated in BID-knockdown cells, still showing some
LTG puncta after 5-h treatment (Fig. 6b). Beclin 1 sup-
pression, clearly evident after 16-h exposure to BSB, was
significantly prevented by BID silencing (Fig. 6c; p < 0.05).
Thus, BID may be directly involved in autophagy down-
regulation and BID-knockdown cells may hold functional
autophagic machinery, potentially rescuing cells from
apoptosis. Indeed, we found that at concentrations up to
80 μM, which were usually associated with an incremental
degree of cell death, BID-silenced cells were significantly
protected from BSB cytotoxicity (Fig. 6d). This makes BID
a proapoptotic and anti-autophagic molecular player,
whose activity is necessary to achieve the full cell death
program of BSB.
Discussion
In the search of novel therapeutic approaches against
cancer, synthetic molecules selectively targeting tumor
surface receptors, oncogenic kinases, or immune check-
points largely predominate, with remarkable results23–25.
However, they usually fail to eradicate the neoplastic
clone. Even in chronic myeloid leukemia, perhaps repre-
senting the clearest example of tyrosine kinase inhibitor
efficacy, the neoplastic stem cell compartment usually
survives due to its basic autophagic, cell-rescuing,
mechanisms26. On the other side, plant-derived com-
pounds have notoriously been considered as dirty mole-
cules, given their propensity to affect numerous
intracellular pathways2. But they should be of interest to
cancer treatment due precisely to their ability to modulate
the eukaryotic autophagic and apoptotic machineries, two
intersected and evolutionarily conserved programs often
dysregulated in cancer cells.
Our study provides evidence that the natural lipophilic
terpene BSB arrests cell cycle and induces neoplastic cell
death through a BID-dependent mechanism. In particular,
BSB (a) selectively accumulated in transformed cells, (b)
triggered BID translocation to lysosomes and mitochon-
dria, (c) permeabilized lysosomal and mitochondrial
membranes leading to cytoplasmic leakage of apoptogenic
factors, as well as bioenergy dissipation, and (d) blocked
the autophagic flux, possibly lowering the threshold for
cell death initiation.
Different cell-free assays have previously shown that
direct interactions between BSB and the non-BH3 domain
of BID are biochemically possible10. In addition, lipids act
as ligands for BID, which is also devoted to their transport
between intracellular membranes15. The subcellular
localization in turn regulates the proapoptotic functions
of the BCL-2 family members27. At resting conditions,
BID is anchored to the plasma membrane or free floating
in the cytoplasm. BSB rapidly increased BID affinity for
specific intracellular membranes, favoring its mobilization
to lysosomes and mitochondria (Fig. 3a, b). This was
meant to have a great impact on the available binding
partners, creating an organelle-centered imbalance
between prosurvival and proapoptotic factors in favor of
the latter. Together with BIM, BID is known to activate
the proapoptotic effectors BAK and BAX, eventually
forming oligomers with membrane-permeabilizing prop-
erties28. In our setting, both full-length and, to a major
extent, tBID were found in the mitochondrial fraction
upon BSB stimulation (Fig. 3c). Thus, BSB binding to BID
may impose specific sublocalizations and increased sen-
sitivity to enzymatic cleavage as well. Alternatively, very
early and still undefined molecular events may link BSB
entry to BID cleavage. In this regard, the upregulation of
specific death receptors29 is one possibility we are cur-
rently testing.
The irreversible damage of lysosomes and mitochondria
had an impact on autophagic and apoptotic pathways.
Despite a transient autophagy induction6, representing
the cell’s attempt to survive, BSB substantially impaired
the autophagic flux through downmodulation of Beclin 1,
which is required for autophagosome maturation18, and
disruption of lysosomal compartment (Fig. 4a–e). AO
relocation to the cytosol, cathepsin B leakage, and
decreased LysoTracker uptake well documented the
lysosomal membrane permeabilization and the loss of
acidic environment typical of lysosomes. This appears to
be mediated, at least in part, by BID activation because
lysosomal membrane of BID-knockdown cells partially
preserved its integrity (Fig. 6b). In addition, BID silencing
completely prevented BSB-induced Beclin 1 suppression
(Fig. 6c). These findings are consistent with a previous
paper where BID was hypothesized to act as a molecular
switch between apoptosis and autophagy30. When BID is
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expressed and activated by BSB, Beclin 1 ends up being
degraded and autophagy collapses; when BID is not
available, Beclin 1 persists and the continuous autophagic
flux probably helps cancer cells survive. Further investi-
gations about BID/Beclin 1 interplay may uncover novel
non-apoptotic functions of BID that are potentially useful
for therapeutic purposes.
Our data show that mitochondrial mechanisms
belonging to intrinsic apoptosis play a role in BSB-
induced cell death. Mitochondria became dysfunctional
under BSB (Fig. 5a–d): their outer membrane was per-
meabilized, the mPTP opened, and the transmembrane
potential progressively declined, an irreversible cascade
associated with organelle fragmentation. The analysis of
BID fate, moving to mitochondria and lysosomes at the
same time, suggested that intrinsic apoptotic pathway and
lysosomal cell death might be triggered in parallel.
Therefore, both mitochondrial and lysosomal death sub-
routines are likely to concur to BSB-induced cell suicide14.
This is consistent with our previous observation that
broad inhibitors of caspases, the very downstream effec-
tors of mitochondrial apoptosis, did not confer substantial
cytoprotection. In contrast, pretreatment with small
molecules that abolished the early autophagy attempts
further unleashed cell death machineries6. As fragmented
mitochondria need to be degraded by functional lyso-
somes to maintain organelle homeostasis31 and avoid
persistent exposure of BID, it is tempting to hypothesize a
self-amplifying mitochondrial–lysosomal death loop pro-
moted by BSB, eventually turning autophagy into a
destructive process. A similar mechanism has already
been proposed for the pentacyclic triterpenoid betulinic
acid32.
Why BSB cytotoxic action preferentially targets cancer
cells over their non-neoplastic counterparts is still an
unanswered point. As shown in Fig. 1d, neoplastic cell
lines took up higher amount of BSB than PBMC, possibly
reaching the threshold concentration that triggers death
cascade. Lipid rafts, which are far more represented in
transformed cells12, positively correlated with intracellular
BSB concentrations and may act as a preferential entry
route, conferring some degree of cancer selectivity.
However, other aspects of basic cancer biology must be
involved. Transformed cells are often primed for death, as
death signaling from oncogenic lesions causes anti-
apoptotic BCL2 family members to sequester high quan-
tities of proapoptotic BH3 proteins. In other words, tumor
cell mitochondria are addicted to their anti-apoptotic
arsenal to prevent MMP33. In this context, massive BSB-
induced BID translocation would disengage the activator
Fig. 6 Rescuing effects of BID knockdown on BSB-treated HeLa cells. a ΔΨm dissipation after 5-h treatment with 40 μM BSB as assessed by JC-1
staining in flow cytometry. The decrease of JC-1 red fluorescence, typical of cells with depolarized mitochondria, is significantly more evident in
control as compared to BID-knockdown cells. b Lysosomal destabilization after 5-h treatment with 40 μM BSB as evaluated by LTG-uptake assay.
Shown is the shift from weak and diffuse cytoplasmic signal (disrupted lysosomes from control-siRNA cells) to a punctate pattern (intact lysosomes
from BID-siRNA cells). Scale bar: 12 μm. c Expression of Beclin 1 in control and BID-knockdown cells after 16-h treatment with 80 μM BSB. Shown
experiments are representative of 3. d Viability as assessed by MTT assay in cells transfected with control-siRNA or BID-siRNA and exposed to 10, 20,
30, 40, and 80 µM BSB for 96 h. Mean values and s.d. of six independent determinations were plotted.
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BIM from its binding partners or directly activate the
effectors BAK/BAX, successfully overwhelming tumor
anti-apoptotic reserves. More generally speaking, the
death priming together with a peculiar genetic repro-
gramming34 might determine the outcome of xeno-
hormesis in cancer cells. Perhaps, dirtiness of plant-
derived molecules2 turns into clinical advantage when
multiple cell death subroutines need to be activated
simultaneously.
In conclusion, we provide evidence that the cytotoxic
effect of BSB passes through BID, which has a non-
redundant role in cell death initiation. Parallel damage of
lysosomes and mitochondria, which ends up causing
autophagy collapse and RCD, characterizes the mode of
action of BSB. Given its preclinical efficacy, low general
toxicity, and affordable cost, we propose BSB as a good
candidate for future anticancer strategies.
Materials and methods
Cells
Normal PBMC were isolated from healthy donors. HeLa
(cervical cancer), Jurkat (acute T cell leukemia), CML-T1,
K562, MEG-01, and LAMA-84 cell lines (blast crisis of
chronic myeloid leukemia) were purchased from DSMZ
(Braunschweig, DE). Cell lines were authenticated routi-
nely and were mycoplasma free. Cells were cultured in
RPMI-1640 (Invitrogen, Carlsbad, CA), supplemented
with 10% heat-inactivated fetal bovine serum (Invitrogen),
50 U/mL streptomycin and 50 U/mL penicillin (complete
medium, CM), and maintained at 37 °C in 5% CO2.
Lipid raft component quantification
The main components of lipid rafts (GM1, flotillin-1,
and cholesterol) were quantified. (1) GM1: Cells were
incubated at 4 °C for 10min with Alexa Fluor 488 cholera
toxin subunit B (CT-B, Invitrogen), which specifically
binds to the pentasaccharide chain of GM1. Cells were
then washed three times with phosphate buffer solution
(PBS) and analyzed by flow cytometry (FACSCalibur or
FACSCantoII, Becton Dickinson, San Jose, CA). (2) Flo-
tillin-1: Cells were fixed, permeabilized by a commercial
kit (eBiosciences, San Diego, CA), and incubated with an
anti-Flotillin-1-Cy3 antibody (Sigma-Aldrich, no. F8931,
St. Louis, MO) for 1 h at 4 °C. After washing, samples
were analyzed by flow cytometry and fluorescence
microscopy. GM1 and flotillin-1 data were expressed in
arbitrary units as the ratio between median fluorescence
intensity of stained cells (subtracted of that of unstained
ones) and median forward scatter (as a surrogate of cell
dimension) multiplied by 104. (3) Cholesterol: The cho-
lesterol content was determined as previously described35,
with minor modifications. The oxidized cholesterol was
separated on a Kinetex C18 column (100 × 4.6 mm,
2.6 μm; Phenomenex, Torrance, CA), using a mobile
phase consisting in 1:99 acetic acid/methanol (v/v) at a
flow rate of 0.4 ml/min with an Agilent 1100 HPLC sys-
tem. Absorbance at λ= 240 nm was monitored by a
photodiode array detector.
BSB extraction
Cells were incubated with 40 μM BSB (Sigma-Aldrich)
for 24 h. Then they were harvested, washed twice with
PBS, and subcellular fractions were obtained according to
Imai et al.36. BSB in subcellular fractions was quantified by
HPLC following Sao Pedro et al.37. All chromatographic
runs were performed with a Waters 510 HPLC system,
Kinetex C18 column (100 × 4.6 mm, 2.6 µm; Phenom-
enex) and Waters 996 Photodiode Array detector. Cali-
bration curves for quantification were generated using
freshly prepared standard solutions at BSB ranging from
0.2 to 5 nmol.
Cell cycle
Jurkat cells were treated with either vehicle (dimethyl
sulfoxide, DMSO; Sigma-Aldrich) or 20, 40, 80 µM BSB
(representing the calculated soluble fraction in the assay
as reported elsewhere5, dissolved in DMSO 1:40) for 24 h
and incubated with 10 μM Vybrant DyeCycle orange
reagent (Life Technologies, Carlsabad, CA) for 15min and
with 1 μM Sytox Blue dead Cell reagent (Life Technolo-
gies) for additionally 15 min to exclude dead cells from
cytometric analysis, as previously reported38.
Apoptosis assay
Jurkat cells were treated for 5 h with 80 μM BSB, washed
with PBS, and incubated with Annexin-V-FITC (Miltenyi
Biotec, Bergisch Gladbach, DE) for 15min. TO-PRO-3
(Invitrogen) was added immediately before the flow
cytometry acquisition.
Cytosolic and mitochondrial fraction preparation, and
western blot
A total of 5 × 106 HeLa cells were treated with 80 μM
BSB for 2, 3, and 5 h. Treatment with 100 μM etoposide
(Sandoz, Origgio, IT) for 24 h was used as positive control
for BID cleavage. After washing, cells were suspended in
10mM NaCl, 1.5 mM MgCl2, 10 mM Tris-HCl, pH 7.5,
1 mM sodium orthovanadate, and complete EDTA-free
protease inhibitor cocktail (Boehringer, Mannheim, DE).
Cells were then chilled on ice for 10 min and gently lysed
by adding 0.3% NP-40. In order to restore an isotonic
environment, a solution containing 525mM mannitol,
175mM sucrose, 12.5 mM Tris-HCl, pH 7.5, 2.5 mM
EDTA, and protease inhibitor cocktail was added. Lysates
were first centrifuged at 600 × g at 4 °C, in order to remove
nuclei, and then the supernatants were centrifugated at
17,000 × g for 30 min at 4 °C. The obtained supernatants
were collected and used as the cytosolic fraction. The
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pellets, which contained mitochondria, were washed once
with the same buffer and then were resuspended in the
sample buffer. The cytosolic and the mitochondrial frac-
tions were separated on a 15% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
and probed using a rabbit polyclonal IgG antibody to BID
(Cell Signaling Technology, no. 2002, Danvers, MA).
Then, the membrane with the cytosolic and mitochon-
drial fractions was probed with a rabbit polyclonal IgG
antibody to α-tubulin (Cell Signaling Technology, no.
2144) and with a mouse monoclonal IgG antibody to
Hsp60 (Cell Signaling Technology, no. 12165).
For the study of PARP, Jurkat cells were homogenized at
4 °C in Lysis Buffer (Thermo Scientific, Rockford, IL) plus
protease inhibitor cocktail (Sigma-Aldrich). Aliquots of
whole-cell lysates (40 μg total protein/lane) were loaded
on SDS–polyacrylamide gels and the resolved proteins
were electroblotted onto a nitrocellulose membrane.
Membranes were then incubated with anti-PARP anti-
body (Zymed Laboratories, no. 333100, South San Fran-
cisco, CA) and with anti-GAPDH antibody (Cell Signaling
Technology, no. 2118). The membranes were then washed
and incubated with a VeriBlot-HRP secondary antibody
(Abcam, no. AB131366, Cambridge, UK). Development
was made by enhanced chemiluminescent plus detection
reagents (Thermo Scientific).
BID transfection
HeLa cells (5 × 104 cells/mL) were seeded in chamber
slides Lab-Tek II (Thermo Fisher Scientific, Waltham,
MA) and let to adhere for 24 h. Then they were trans-
fected for 48–72 h by Fugene HD (Promega, Madison,
WI) with 0.5 μg pDsRed2-BID expression vector (Clono-
tech, Mountain View, CA). They were stained with
MitoTracker Deep Red FM or MitoTracker Green FM
(150 nM, Invitrogen) and LysoTracker Green DND-26
(50 nM, Invitrogen) for 30min, 80 μM BSB added, and
monitored for 3 h by time-lapse imaging confocal
microscopy (Leica TCS-SP5 equipped with an incubator
with temperature and CO2 controllers, Wetzlar, DE).
Images, captured every 10min, and movies were elabo-
rated by using LAS-AF and Imaris software.
BID silencing
HeLa cells were cultured in 96-well plates and trans-
fected by Lipofectamine RNAiMAX Reagent (Thermo
Fisher Scientific) with a mix of two specific BID-siRNA
(small interfering RNA; 1.2+ 1.2 pM, Silencer selected
validated siRNA; Invitrogen) or control-siRNA for 48 h.
Then they were exposed for 96 h to 10, 20, 30, 40, and
80 μM BSB. Silencing was checked by western blotting. At
the end of the culture, viability was measured by MTT
(Sigma-Aldrich) incorporation, as previously described39.
Viability was expressed as the ratio between the number
of cells treated with BSB and the number of cells treated
with the vehicle alone in each condition.
Detection of autophagic flux
Jurkat cells were treated with vehicle or 80 μM BSB for
16 h. They were harvested, washed in cold PBS, and
resuspended in Lysis Buffer (Thermo Fisher Scientific)
plus protease inhibitor cocktail (Sigma-Aldrich). Whole-
cell lysates were separated on a 12% SDS–PAGE and
analyzed by immunoblotting as described above.
LC3: In order to inhibit the degradation of autophagic
cargo, Pepstatin A (Sigma-Aldrich, 10 μg/mL) and E-64D
(Sigma-Aldrich, 10 μg/mL) were added to the media.
Membranes were tested with anti-LC3 (Cell Signaling
Technology, no. 12741) and anti-GAPDH antibodies (Cell
Signaling Technology, no. 2118).
Beclin 1: Membranes were tested with anti-Beclin 1
(Cell Signaling Technology, no. 3495) and anti-GAPDH
antibodies. Control and BID-knockdown Hela cells were
also tested.
RNA isolation and reverse transcription quantitative real‐
time polymerase chain reaction
Total cellular RNA was purified by EuroGold Trifast kit
(Euroclone, Pero, IT) from HeLa and Jurkat cells treated
with either vehicle or 80 μM BSB for 6 and 16 h. Tem-
plates were generated from 1 μg of RNA by the High
Capacity cDNA Reverse Transcription kit (Applied Bio-
systems, Foster City, CA). Beclin 1 (TaqMan assay ID
Hs1007018_m1, Thermo Fisher Scientific) and GAPDH
internal control (Hs99999905_m1, Thermo Fisher Scien-
tific) were coamplified with the Taqman Fast Advanced
Master Mix (Thermo Fisher Scientific) in technical
duplicate using the 7500 Real time PCR System (Applied
Biosystems). The thermal cycling conditions were as fol-
lows: 50 °C for 2 min, 95 °C for 2 min, followed by 40
cycles of denaturing at 95 °C for 3 s, and annealing at
60 °C for 30 s. The relative expression levels of Beclin 1
were determined by the 2−ΔΔCt method. Data are
expressed as fold change.
Lysosome damage assays
(1) LTG-uptake assay: Jurkat and BID-knockdown HeLa
cells were incubated with 80 μM BSB for 5 h. Then they
were washed and stained at 37 °C for 1 h with 75 nM of
the acidotropic dye LTG (Molecular Probes, Eugene, OR),
spotted onto a slide (HeLa were detached with trypsin),
mounted with a coverslip, and immediately recorded by
confocal microscopy. (2) AO-relocation assay: Jurkat cells
were stained with 0.5 μg/mL AO (Molecular Probes) at
37 °C for 15min, washed twice, treated with 80 μM BSB
for 5 h, and evaluated by flow cytometry (FL-1 channel). An
aliquot of each sample was spotted onto a slide, mounted
with a coverslip, and immediately recorded by confocal
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microscopy. (3) AO-uptake assay: Jurkat cells were incu-
bated with 80 μM BSB for 5 h and stained with 0.5 μg/mL
AO for 15min at 37 °C, washed twice and analyzed by flow
cytometry (FL-3 channel). An aliquot of each sample was
spotted onto a slide, mounted with a coverslip, and
immediately recorded by confocal microscopy. (4) Cathe-
psin B immunofluorescence staining: Jurkat cells were
grown on slides until semiconfluence, exposed to 80 μM
BSB for 5 h, and treated as previously described7. Briefly,
after fixing they were incubated with a rabbit monoclonal
antibody to human cathepsin B (Abcam, no. AB125067),
developed with a goat anti-rabbit Alexa Fluor 568-
conjugated antibody (Invitrogen, no. A11011), counter-
stained with DAPI, and imaged by an Axio Observer
inverted microscope (Zeiss, Gottingen, DE).
Mitochondrial damage assays
(1) ΔΨm: As previously described
8, Jurkat cells were
resuspended in CM and treated with 40 μM BSB for 3 and
5 h at 37 °C. Then, they were washed with prewarmed
CM, loaded with 4 μM JC-1 (5,5′,6,6′-tetra-chloro-
1,1′,3,3′-tetra-ethyl-benz-imidazolyl-carbo-cyanine
iodide, Molecular Probes) for 30 min, then washed twice
with PBS. Aliquots of each sample were resuspended in
PBS and analyzed by flow cytometry or spotted onto a
slide, and recorded by an Axio Observer inverted micro-
scope. Visualization of JC-1 monomers and JC-1 aggre-
gates was done using filter sets for fluorescein and
rhodamine dyes, respectively. Image analysis was per-
formed using Axiovision 3 software. Control and BID-
knockdown Hela cells were also tested. (2) ΔΔΨm mea-
surement: Cells treated with 20, 40, 80 μM BSB for 5 h
were incubated with 100 nM TMRM for 30min at 37 °C.
Then they were washed with PBS and subjected to flow
cytometry. (3) mPTP: Cells were treated with 40 μM BSB
for 5 h. Then, they were washed, resuspended in HBSS/
Ca2+, loaded with 10 nM calcein AM with or without
400 μM CoCl2 for 15 min at 37 °C (MitoProbe Transition
Pore assay kit, Invitrogen), and analyzed by flow cyto-
metry. An aliquot of each sample was spotted onto a slide,
mounted with a coverslip, and immediately recorded by
confocal microscopy.
(4) Mitochondrial morphology: HeLa cells were plated
in ibiTreat m-Slide 15 Well (Ibidi, Gräfelfing, DE) at a
density of 3 × 104/well with 50 µl CM, and incubated
overnight at 37 °C in a humidified atmosphere and 5%
CO2. Afterward, cells were transfected with a plasmid
carrying the GFP targeted to mitochondria (CellLight
Mitochondria-GFP, BacMam 2.0; Thermo Fisher Scien-
tific) and exposed to 80 µM BSB or vehicle for 24 h.
Mitochondrial network morphology was assessed by live-
cell imaging using Nikon C1si confocal microscope
(Tokyo, JP). The aspect ratio was employed as a mito-
chondrial morphometric parameter, according to Marchi
et al.40 Image J standard tools were used to analyze
images.
Statistics
Continuous variables were presented as the mean ± s.d.,
unless otherwise specified. When appropriate, data were
summarized by percentages. Mann–Whitney U test was
used to analyze the difference between means.
Kruskall–Wallis test (or Friedman test for matched data)
followed by Dunn’s multiple comparisons test were used
to analyze the differences between multiple means. Data
had normal distribution. Presented data meet the
assumptions of the tests. Differences were considered as
significant for p < 0.05. Analyses were performed using
the statistical software Stata 12.1.
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